An association of the MCP-1 and CCR2 gene polymorphisms with oral lichen planus

Oral Surg Oral Med Oral Pathol Oral Radiol. 2021 Dec;132(6):708-714. doi: 10.1016/j.oooo.2021.06.009. Epub 2021 Jun 21.

Abstract

Objective: The purpose of this study was to investigate the frequency of monocyte chemoattractant protein (MCP)-1 CCR2 gene polymorphisms in Turkish patients with oral lichen planus (OLP).

Study design: A cohort of 50 patients with OLP and 142 control participants without OLP were recruited to investigate the frequency of MCP-1 and CCR2 gene polymorphisms. Chi-square and Fisher's exact tests were used. Student t test and analysis of variance were used to compare demographic data between groups.

Results: The MCP AA genotype was less common in the patient group (52%) than in the control group (66.2%; odds ratio [OR] = 0.553; 95% confidence interval [CI], 0.287-1.065; P = .075). The MCP G allele was higher in the patient group (48%) than in the control group (33.8%; OR = 1.808; 95% CI, 0.939-3.479; P = .075). The frequency of the MCP GG genotype was observed to be higher in the patient group (4%) than in the controls (0.7%; OR: 5.875, 95% CI:0.521-66,24; p = 0.106). The CCR2 64I64I genotype was more common in the patient group (6%) than in the control group (2.8%). All results were not statistically significant.

Conclusion: We suggest that the G allele of MCP-1 and 64I64I genotype of CCR2 polymorphisms do not pose an increased risk for Turkish patients with OLP to develop oral squamous cell carcinoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Squamous Cell
  • Case-Control Studies
  • Chemokine CCL2 / genetics*
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Lichen Planus, Oral* / genetics
  • Mouth Neoplasms
  • Polymorphism, Single Nucleotide
  • Receptors, CCR2* / genetics
  • Turkey

Substances

  • CCL2 protein, human
  • CCR2 protein, human
  • Chemokine CCL2
  • Receptors, CCR2